DalianbaojiehuagongkejiyouxiangongsiContact us
Dalianbaojiehuagongkejiyouxiangongsi
[China]
TAE 684 is a potent, selective, and efficacious inhibitor of NPM-ALK, a fusion protein that is a key regulator of oncogenic events that drives the survival and proliferation of anaplastic large-cell lymphomas.
here are our new list:
| PS48 | cas:1180676-32-7 |
| Bosutinib(SKI-606) | cas:380843-75-4 |
| Asunaprevir(BMS-650032) | cas:630420-16-5 |
| INT-747 | cas:459789-99-2 |
| FH535 | cas:108409-83-2 |
| ML323 | cas:1572414-83-5 |
| EMD-1214063 | cas:1100598-32-0 |
| Tivozanib (AV-951) | cas:475108-18-0 |
| FG4592 intermediate 3 | cas:1537180-07-6 |
| CID755673 | cas:521937-07-5 |
| GSK2636771 | cas:1372540-25-4 |
| whi-p154 | cas:211555-04-3 |
| AS-252424 | cas:900515-16-4 |
| INCB28060 | cas:1029712-80-8 |
| CNX1351 | cas:1276105-89-5 |
| NV--TAE684 | cas:761439-42-3 |
| NVP-AEW541 | cas:474589-16-8 |
| ARRY-543 | cas:114629-86-8 |
| tomeglovir | cas:233254-24-5 |
| OTSSP167HCL | cas:1431698-10-0 |
| YC-6 | cas:4725-51-3 |
| TAS-103 | cas:174634-09-4（2HCl） |
| PF-04217903 | cas:956905-27-4 |
| K145 | cas:1449240-68-9（HCl） |
| PFI-1 | cas:1403764-72-6 |
| GNZ-644282 | cas:529488-28-6 |
| A-83-01AB142092) | cas:909910-43-6 |
| CH5138303 | cas:959763-06-5 |
| GOSH75020 | cas:12478-37-1 |
| B-RAF | cas:1093100-40-3 |
| Losmapimod,GW-856553 | cas:585543-15-3 |
| AMG-706 | cas:857876-30-3 |
| TMP-269 | cas:1314890-29-3 |
| JQ-1 | cas:1268524-70-4 |
| CPI203 | cas:1446144-04-2 |
| TH-237A | cas:935467-97-3 |
| ONX0914(PR-957) | cas:960374-59-8 |
| XEN-445 | cas:1515856-92-4 |
| Purmorphamine | cas:483367-10-8 |
| Ivacaftor (VX-770) | cas:873054-44-5 |
| PD0332991 | cas:827022-32-2 |
| VX770 | cas:873054-44-5 |
| NSC 405020 | cas:7497-07-6 |
| TMP269 | cas:1314890-29-3 |
| Nexturastat A | cas:1403783-31-2 |
| JAK2 Inhibitor V, Z3, | cas:195371-52-9 |
| Kartogenin | cas:4727-31-5 |
| PS48 | cas:1180676-32-7 |
| 阿瑞吡坦 | cas:170729-80-3 |
| L-754 030 | cas:221350-96-5 |
| Deferitrin | cas:239101-33-8 |
| SVT40776 | cas:385367-47-5 |
| SP420 | cas:911714-45-9 |
| Tarafenacin | cas:385367-47-5 |
| 安丝菌素P-3ansamitocin P-3 | cas:66547-09-9 |
| 戊柔比星 | cas:56124-62-0 |
| 吡柔比星 Pirarubicin | cas:72496-41-4 |
| 埃博霉素 | cas:189453-10-9 |
| 莫西菌素 Moxidectin | cas:113507-06-5 |
| VRT752271(HCL) | cas:869886-67-9 |
| ALK INHIBITOR2 | cas:761438-38-4 |
| MK8745 | cas:885325-71-3 |
| roscovitin | cas:186692-44-4 |
| 凡德他尼vandetanib | cas:443913-73-3 |
| GSK126 | cas:1112980-86-5 |
| MX1013 | cas:582316-00-5 |
| 丝裂菌素 | |
| BMS 201038-04 | cas:202914-84-9 |
| Rolapitant(sch619734)粘状物 | cas:552292-08-7 |
| p7c3-a20 | cas:1235481-90-9 |
| 替格瑞洛TICAGRELOR | cas:274693-27-5 |
| 托法替布 | |
| 鲁拉西酮 lurasidone | cas:367514-87-2 |
| VS-4718(PND1186) | cas:1061353-68-1 |
| WH-4-023 | cas: 837422-57-8 |
| AMG-706 | cas:857876-30-3 |
| BMS303141 | cas:943962-47-8 |
| TMP-269 | cas:1314890-29-3 |
| Lasmiditan (COL-144; LY573144) | cas:439293-90-4 |
| Losmapimod,GW-856553 | cas:585543-15-3 |
| A966492 | cas:931462-61-5 |
| AMG-47a | cas:882663-88-9 |
| EPz6438 | cas:1403254-99-8 |
| EPz005687 | cas:1396772-26-1 |
| cas:1208123-85-6 | |
| 4EGI-1 | cas:315706-13-9 |
| AdipiRon | |
| cas:4190-83-4 | |
| EHT 1864 | cas:754240-09-0 |
| INH1 | cas:313553-47-8 |
| INH6 | cas:1001753-24-7 |
| Remodelin | cas:1622921-15-6 |
| E7010(ABT-751) | cas:141430-65-1 |
| PL-100 | cas:612547-11-2 |
| AC55541 | cas:916170-19-9 |
| ZK-811752(BX-471) | cas:217645-70-0 (free base) |
| PFI-3 | cas:1819363-80-8 |
| LY2835219 | cas:1231929-97-7 |
| D-64131(sc-203908) | cas:74588-78-6 |
| JW55 | cas:664993-53-7 |
| 7-ACC2 | cas:1472624-85-3 |
Other products from this supplier
Related products from premium suppliers on EC21
Browse: Manufacturer Directory Countries China India Korea Premium Suppliers Community Site Map
About EC21 Contact Us Terms & Conditions Report Item Online Trading Risks Product Listing Policy
中文 繁體 한국어 日本語 Español Русский Français Deutsch
Copyright (c)1997-2021 EC21 Inc. All Rights Reserved. EC21 in KoreanChinese
Business Registry Number: 120-86-03931
){kind=link}